Trends in mRNA Vaccine Research

Zusatztext

<p><b>The authoritative guide to the revolutionary concept behind the successful Covid-19 vaccines</b><p>In<i>Trends in mRNA Vaccine Research</i>, a team of distinguished researchers delivers a practical and up-to-date discussion of the biochemical and biomedical foundations of mRNA vaccines. They also explore the manufacturing conditions required for successful vaccine development and review recent progress in a variety of medical fields, including vaccines against pathogens like SARS-CoV-2, HIV, plasmodium,<i>Mycobacterium tuberculosis</i>, as well as anticancer vaccines.<p>Volume highlights include:<ul><li>A historical overview of mRNA vaccine development</li><li>Immune responses to modified or unmodified mRNA vaccines</li><li>A description of the different mRNA vaccine platforms</li><li>Latest data on current mRNA vaccine developments against infectious diseases and cancer</li></ul><p>Perfect for medicinal chemists, immunologists, and epidemiologists,<i>Trends in mRNA Vaccine Research</i> will also benefit researchers and scientists working in the pharmaceutical industry, as well as cancer researchers with an interest in vaccine development.

Autorenportrait

<p><b>Gabor Tamas Szabo, MD, PhD,</b> is an Associate Director at BioNTech SE. His work is focuses on mRNA technology optimization and applications.</p><p><b>Norbert Pardi, PhD,</b> is an Assistant Professor at the University of Pennsylvania, USA. His research is focused on the development of mRNA-based therapeutics with a focus on vaccines.</p>

Weitere Details